Onaiza Cadoret Manier Ionis Pharmaceuticals Inc (IONS) insider trading activity

Onaiza Cadoret Manier is EVP, Chf GL Pdt Str & Oper Ofc of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 35,825 shares of IONS, which is worth approximately $1.38 Million. The most recent transaction as insider was on Feb 02, 2024, when has been sold 2,125 shares (Common Stock) at a price of $49.6 per share, resulting in proceeds of $105,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.8K

0% 3M change

47.36% 12M change

Total Value Held $1.38 Million

Onaiza Cadoret-Manier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 02 2024	SELL Open market or private sale	$105,400 $49.6 p/Share	2,125 Reduced 5.6%	35,825 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	4,140 Added 9.84%	37,950 Common Stock
Jan 17 2024	SELL Open market or private sale	$280,536 $50.42 p/Share	5,564 Reduced 14.13%	33,810 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	-	15,062 Added 27.67%	39,374 Common Stock
Apr 18 2023	SELL Open market or private sale	$94,243 $36.5 p/Share	2,582 Reduced 9.6%	24,312 Common Stock
Apr 17 2023	BUY Exercise of conversion of derivative security	-	5,667 Added 17.4%	26,894 Common Stock
Feb 06 2023	SELL Open market or private sale	$58,997 $40.66 p/Share	1,451 Reduced 6.4%	21,227 Common Stock
Feb 03 2023	BUY Grant, award, or other acquisition	-	4,140 Added 15.44%	22,678 Common Stock
Jan 18 2023	SELL Open market or private sale	$148,233 $39.55 p/Share	3,748 Reduced 16.82%	18,538 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	10,197 Added 31.39%	22,286 Common Stock
Apr 18 2022	SELL Payment of exercise price or tax liability	$80,380 $41.01 p/Share	1,960 Reduced 13.95%	12,089 Common Stock
Apr 18 2022	BUY Exercise of conversion of derivative security	-	5,667 Added 28.74%	14,049 Common Stock
Jan 18 2022	SELL Payment of exercise price or tax liability	$69,427 $30.12 p/Share	2,305 Reduced 21.57%	8,382 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	-	6,057 Added 36.17%	10,687 Common Stock
Aug 31 2021	BUY Other acquisition or disposition	$14,568 $33.8 p/Share	431 Added 8.52%	4,630 Common Stock
Apr 15 2021	SELL Payment of exercise price or tax liability	$80,419 $41.03 p/Share	1,960 Reduced 31.82%	4,199 Common Stock
Apr 15 2021	BUY Exercise of conversion of derivative security	-	5,667 Added 47.92%	6,159 Common Stock
Feb 26 2021	BUY Other acquisition or disposition	$21,914 $44.54 p/Share	492 Added 50.0%	492 Common Stock

Also insider at

ARDX

ARDELYX, INC. Healthcare

Director

VTYX

Ventyx Biosciences, Inc. Healthcare